Curcumin containing monoolein aqueous dispersions: A preformulative study

Materials Science and Engineering C

Volumn 33, Issue 8, 2013, Pages 4923-4934

  Esposito, Elisabetta ^a   Ravani, Laura ^a   Mariani, Paolo ^c   Contado, Catia ^a   Drechsler, Markus ^d   Puglia, Carmelo ^b   Cortesi, Rita ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Cryo Transmission Electron Microscopy; Cubosomes; Curcumin; Franz cell; Monoolein; Sedimentation Field Flow Fractionation

Indexed keywords

ELECTRON MICROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIQUID CHROMATOGRAPHY; MIXTURES; NANOSYSTEMS; PHOTON CORRELATION SPECTROSCOPY; SODIUM; TRANSMISSION ELECTRON MICROSCOPY;

CRYO-TRANSMISSION ELECTRON MICROSCOPY; CUBOSOMES; CURCUMIN; FRANZ CELL; MONOOLEIN; SEDIMENTATION FIELD FLOW FRACTIONATION;

DISPERSIONS;

ACYLGLYCEROL; CHOLIC ACID; CURCUMIN; DRUG CARRIER; GLYCEROL OLEATE; LIPOSOME; POLOXAMER; CHROMIUM;

ADULT; CHEMISTRY; EPIDERMIS; HUMAN; METABOLISM; PH; SKIN ABSORPTION; VISCOSITY; ARTICLE; CRYO-TEM; CRYO-TRANSMISSION ELECTRON MICROSCOPY; CUBOSOMES; FIELD FLOW FRACTIONATION; FRANZ CELL; MAD; MONOOLEIN AQUEOUS DISPERSIONS; SCE; SDFFF; STRATUM CORNEUM EPIDERMIS;

ADULT; CURCUMIN; DRUG CARRIERS; EPIDERMIS; GLYCERIDES; HUMANS; HYDROGEN-ION CONCENTRATION; POLOXAMER; SKIN ABSORPTION; SODIUM CHOLATE; UNILAMELLAR LIPOSOMES; VISCOSITY;

CR; CRYO-TEM; CRYO-TRANSMISSION ELECTRON MICROSCOPY; CUBOSOMES; CURCUMIN; FRANZ CELL; MAD; MONOOLEIN; MONOOLEIN AQUEOUS DISPERSIONS; SCE; SDFFF; SEDIMENTATION FIELD FLOW FRACTIONATION; STRATUM CORNEUM EPIDERMIS;

EID: 84885191332     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2013.08.017     Document Type: Article

References (46)

1. A.M. Anderson, M.S. Mitchell, R.S. Mohan, Isolation of curcumin from turmeric, J. Chem. Educ. 77 (2000) 359-360.
2. I. Chattopadhyay, K. Biswas, U. Bandyopadhyay, R.K. Banerjee, Turmeric and curcumin. Biological actions and medicinal applications, Curr. Sci. 87 (2004) 44-50.
3. B.B. Aggarwal, K.B. Harikumar, Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases, Int. J. Biochem. Cell Biol. 41 (2009) 40-59.
4. J.S. Jurenka, Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research, Altern. Med. Rev. 14 (2009) 141-153.
5. S.H. Jee, S.C. Shen, C.R. Tseng, H.C. Chiu, M.L. Kuo, Curcumin induces ap53-dependent apoptosis in human basal cell carcinoma cells, J. Invest. Dermatol. 111 (1998) 656-661.
6. R.L. Thangapazham, A. Sharma, R.K. Maheshwari, Beneficial role of curcumin in skin diseases, Adv. Exp. Med. Biol. 595 (2007) 343-357.
7. B. Bhawana, R.K. Basniwal, H.S. Buttar, V.K. Jain, N. Jain, Curcumin nanoparticles: preparation, characterization, and antimicrobial study, J. Agric. Food Chem. 59 (2011) 2056-2061.
8. A. Yaghmur, O. Glatter, Characterization and potential applications of nanostruc-tured aqueous dispersions, Adv. Colloid Interf. Sci. 147 (2009) 333-342.
9. B. Siekmann, H. Bunjes, M.H.J. Koch, K. Westesen, Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride/water phases, Int. J. Pharm. 244 (2002) 33-43.
10. E. Esposito, N. Eblovi, S. Rasi, M. Drechsler, G.M. Di Gregorio, E. Menegatti, R. Cortesi, Lipid based supramolecular systems for topical application: a preformulatory study, AAPS PharmSci. 5 (2003) E30.
11. V. Luzzati, H. Delacroix, A. Gulik, T. Gulik-Krzywicki, P. Mariani, R. Vargas, The cubic phases of lipids, Curr. Top. Membr. 44 (1997) 3-24.
12. J. Gustafsson, H. Ljusberg-Wharen, M. Almgrem, K. Larsson, Cubic lipid/water phase dispersed into submicron particles, Langmuir 12 (1996) 4611-4613.
13. L. De Campo, A. Yaghmur, L. Sagalowicz, M.E. Leser, H. Watzke, O. Gattler, Reversible phase transitions in emulsified nanostructured lipid systems, Langmuir 20 (2004) 5254-5261.
14. E. Esposito, P. Mariani, L. Ravani, C. Contado, M. Volta, S. Bido, M. Drechsler, S. Mazzoni, E. Menegatti, M. Morari, R. Cortesi, Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study, Eur. J. Pharm. Biopharm. 80 (2012) 306-314.
15. G. Worle, M. Drechsler, M.H.J. Koch, B. Siekmann, K. Westesen, H. Bunjes, Influence of composition and preparation parametersonthe propertiesof aqueous monoolein dispersions, Int. J. Pharm. 329 (2007) 150-157.
16. J. Gustafsson, H. Ljusberg-Wharen, M. Almgrem, K. Larsson, Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer, Lang-muir 13 (1997) 6964-6971.
17. K. Larsson, Aqueous dispersion of cubic lipid/water phases, Curr. Opin. Colloid Interface Sci. 5 (2000) 64-69.
18. P. Mariani, V. Luzzati, H. Delacroix, Cubic phases of lipid containing systems. Structure analysis and biological implications, J. Mol. Biol. 204 (1988) 165-189.
19. R. Pecora, Dynamic light scattering measurement of nanometer particles in liquids, J. Nanoparticle Res. 2 (2000) 123-131.
20. C. Contado, G. Blo, F. Fagioli, F. Dondi, R. Beckett, Characterisation of River Po particles by sedimentation field-flow fractionation coupled to GFAAS and ICP-MS, Colloids Surf. A: Physicochem. Eng. Aspect 120 (1997) 47-59.
21. E. Esposito, L. Ravani, C. Contado, A. Costenaro, M. Drechsler, D. Rossi, E. Menegatti, A. Grandini, R. Cortesi, Clotrimazole nanoparticle gel for mucosal administration, Mat. Sci. Eng. C 33 (2013) 411-418.
22. E. Toitou, B. Fabin, Altered skin permeation of highly lipophilic molecule: tetrahy-drocannabinol, Int. J. Pharm. 43 (1988) 17-22.
23. N.A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.
24. A.M. Kligman, E. Christophers, Preparation of isolated sheets of human stratum corneum, Arch. Dermatol. 88 (1963) 702-705.
25. C. Puglia, F. Bonina, L. Rizza, R. Cortesi, E. Merlotti, M. Drechsler, P. Mariani, C. Contado, L. Ravani, E. Esposito, Evaluation of percutaneous absorption of naproxen from different liposomal formulations, J. Pharm. Sci. 99 (2010) 2819-2829.
26. R.L. Bronaugh, R.F. Stewart, M. Simon, Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin, J. Pharm. Sci. 75 (1986) 1049-1097.
27. M. Siewert, J. Dressman, C.K. Brown, V.P. Shah, FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms, AAPS PharmSciTech 4 (2003) E7.
28. M. Lindstrom, H. Ljusberg-Wahren, K. Larsson, B. Borgstrom, Aqueous lipid phases of relevance to intestinal fat digestion and absorption, Lipids 16 (1981) 749-754.
29. F. Caboi, J. Borne, T. Nylander, A. Khan, A. Svendsen, S. Patkar, Lipase action on a monoolein/sodium oleate aqueous cubic liquid crystalline phase-a NMR and X-ray diffraction study, Colloids Surf. B: Biointerfaces 26 (2002) 159-171.
30. W. Buccheim, K. Larsson, Cubic lipid-protein-water phases, J. Colloid Interface Sci. 117 (1987) 582-583.
31. M. Golding, A. Sein, Surface rheology of aqueous casein-monoglyceride dispersions, Food Hydrocoll. 18 (2004) 451-461.
32. J. Zhai, L. Waddington, T.J. Wooster, M.-I. Aguilar, B.J. Boyd, Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles, Langmuir 27 (2011) 14757-14766.
33. G. Began, E. Sudharshan, K. Udaya Sankar, A.G. Appu Rao, Interaction of curcumin with phosphatidylcholine: a spectrofluorometric study, J. Agric. Food Chem. 47 (1999) 4992-4997.
34. Y.J. Wang, M.-H. Pan, A.-L. Cheng, L.-I. Lin, Y.-S. Ho, C.-Y. Hsieh, J.-K. Lin, Stability of curcumin in buffer solutions and characterization of its degradation products, J. Pharm. Biomed. Anal. 15 (1997) 1867-1876.
35. L.C. Price, R.W. Buescher, Decomposition of turmeric curcuminoids as affected by light, solvent and oxygen, J. Food Biochem. 20 (1996) 125-133.
36. L.C. Price, R.W. Buescher, Kinetics of alkaline degradation of the food pigments curcumin and curcuminoids, J. Food Sci. 62 (1997) 267-269.
37. H.H. Tonnesen, M. Masson, T. Loftsson, Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability, Int. J. Pharm. 244 (2002) 127-135.
38. C. Puglia, V. Cardile, A.M. Panico, L. Crascì, A. Offerta, S. Caggia, M. Drechsler, P. Mariani, R. Cortesi, E. Esposito, Evaluation of monooleine aqueous dispersions as tools for topical administration of curcumin: characterization, in vitro and ex-vivo studies, J. Pharm. Sci. 102 (2013) 2349-2361.
39. E. Esposito, S. Mazzitelli, R. Cortesi, M. Drechsler, L. Ravani, C. Nastruzzi, Analysis of the drug release profiles from formulations based on micro and nano systems, Curr. Anal. Chem. 9 (2013) 37-46.
40. V. Venkateswarlu, K. Manjunath, Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles, J. Control. Release 95 (2004) 627-638.
41. L.C. Herrera, M.V. Defain Tesoriero, L.G. Hermida, In vitro release testing of PLGA mi-crospheres with Franz diffusion cells, Dissolut. Technol. 5 (2012) 6-11.
42. D.-B. Chen, T.-Z. Yang, W.-L. Lu, Q. Zhang, In vitro and in vivo study of two types of long-circulating solid lipid nano-particles containing paclitaxel, Chem. Pharm. Bull. 49 (2001) 1444-1447.
43. H. Chung, S.Y. Jeong, I.C. Kown, Cubic liquid-crystalline particles as protein and insoluble drug delivery systems, in: M.L. Lynch, P.T. Spicer (Eds.), Bicontinuous Liquid Crystals, CRC Press, Taylor & Francis Group, Boca Raton (FL), 2005, pp. 353-385.
44. E. Esposito, E. Menegatti, R. Cortesi, Hyaluronan based microspheres as tools for drug delivery: a comparative study, Int. J. Pharm. 288 (2005) 35-49.
45. J. Lee, I.W. Kellaway, The controlled release of drugs from cubic phases of glyceryl monooleate, in: M.L. Lynch, P.T. Spicer (Eds.), Bicontinuous Liquid Crystals, CRC Press, Taylor & Francis Group, Boca Raton (FL), 2005, pp. 457-469.
46. E. Esposito, R. Cortesi, M. Drechsler, L. Paccamiccio, P. Mariani, C. Contado, E. Stellin, E. Menegatti, F. Bonina, C. Puglia, Cubosome dispersions as delivery systems for percutaneous administration of indomethacin, Pharm. Res. 22 (2005) 2163-2173.